Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology’s Solid Tumor Medical Advisory Board
Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, proudly announces that Dr. Gerard Blobe,
Geneticure Announces Technology to Drive an Estimated 250% Increase in Renal Denervation Adoption Using Genetic
Studies demonstrate that approx. 1 in 3 patients with renal denervation do not have a meaningful drop in Blood Pressure
Explora BioLabs Opens New Preclinical Vivarium in S. San Francisco, Calif.
Post Views: 244 Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San Diego, opened a new facility in January. The new vivarium, located at East Jamie Court in The East Side neighborhood of South San Francisco, is Explora BioLabs’ seventh San Francisco facility. The new East Jamie…
iMetabolic Biopharma Corporation (iMBP) Teams With Amazon Web Services (AWS) Diagnostic Development Initiative
Post Views: 335 Biopharma Corporation (iMBP) announces it has teamed with Amazon Web Services (AWS) to aid in the development of its proprietary iPlatform™ technology. Selected through AWS’s Diagnostic Development Initiative, iMBP and AWS are cooperatively working together in developing collective solutions to address COVID-19 and other infectious diseases. Through the initiative, AWS – Amazon’s…
Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference
Post Views: 265 Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, will present at the upcoming 2022 BIO CEO & Investor Conference, which will be held in New York City on February 14-17, 2022. Hosted by the Biotechnology Innovation Organization (BIO) for over 20 years, the annual event is focused on emerging…
Positive Results for Lipid inCode® in NHS Clinical Study
Post Views: 247 GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and positive results for its Lipid inCode® test (“Lipid inCode®”) for hypercholesterolemia (high levels of cholesterol), including Familial Hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals (“RB&H”),…
Gens & Associates Extends Executive Lounge Membership
Post Views: 265 Gens & Associates, one of the most respected benchmarking and advisory firms in Life Sciences, is extending the value of its Executive Lounge to the regulatory community by offering membership beyond those organizations just participating in its benchmark studies or advisory services. Highly regarded for its World-Class Regulatory Information Management (RIM) benchmark…
TeselaGen Secures Contract from BioMADE to Accelerate US Biomanufacturing with Advanced Informatics and Artificial Intelligence
Post Views: 255 TeselaGen Biotechnology announced today a two-year contract with BioMADE, the Department of Defense-sponsored bioindustrial Manufacturing Innovation Institute, to improve the informatics infrastructure around fermentation-based biomanufacturing. As part of this collaboration, TeselaGen will develop novel technologies that standardize data exchange, connect disparate software systems, and establish secure protocols to facilitate collaboration on AI-enabled…
CS Analytical CSO Brandon Zurawlow to Lead IPP Container Closure Integrity Testing (CCIT) Seminar
Post Views: 238 CS Analytical Laboratory, the world’s only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that Chief Scientific Officer Brandon Zurawlow will lead the CCI training course at the Industrial Production Processes (IPP) Ltd Container Closure…
Memorial Cancer Institute First in South Florida, and Among First in U.S., to Use Innovative Technology for Early Detection of Lung Cancer
Post Views: 225 More than 90 percent of people diagnosed with lung cancer do not survive the disease, usually because it is already advanced at the time it is discovered. For 20 years Memorial Cancer Institute has been at the forefront of innovation in the fight against lung cancer and is proud to announce its…
